Clinical Trial Update: A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer [NA]

View source ↗

Summary

A single-arm, multicenter Phase II trial evaluating camrelizumab combined with famitinib as adjuvant therapy after radical resection of cervical cancer; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)
• Famitinib (Famitinib)

Snippet

Sponsor: Jin LI | Conditions: Cervical Cancer, Radical Surgery | NA | Status: NOT_YET_RECRUITING